IO Biotech, Inc.IOBTNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank77
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P77
Within normal range
vs 2Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 6.88% |
| Q2 2025 | 14.07% |
| Q1 2025 | -17.64% |
| Q4 2024 | 5.68% |
| Q3 2024 | -22.50% |
| Q2 2024 | 31.87% |
| Q1 2024 | -8.89% |
| Q4 2023 | -43.04% |
| Q3 2023 | 12.50% |
| Q2 2023 | -23.34% |
| Q1 2023 | -15.25% |
| Q4 2022 | 4.39% |
| Q3 2022 | -2.65% |
| Q2 2022 | 37.41% |
| Q1 2022 | -8.10% |
| Q4 2021 | -137.22% |
| Q3 2021 | 13.05% |
| Q2 2021 | -141.55% |
| Q1 2021 | -25.79% |
| Q4 2020 | -43.11% |
| Q3 2020 | -91900.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |